Printed From BioPortfolio.com
Achillion Pharmaceuticals, Inc. (ACHN) Shares Bought by Cambridge Investment Research Advisors Inc.
10:42 EDT 24 Sep 2017 | Topix
Cambridge Investment Research Advisors Inc. increased its holdings in Achillion Pharmaceuticals, Inc. by 3.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,130 shares of the biopharmaceutical company's stock after acquiring an additional 800 shares during the period.
Original Article: Achillion Pharmaceuticals, Inc. (ACHN) Shares Bought by Cambridge Investment Research Advisors Inc.
